000 | 01716 a2200457 4500 | ||
---|---|---|---|
005 | 20250517112559.0 | ||
264 | 0 | _c20171010 | |
008 | 201710s 0 0 eng d | ||
022 | _a1879-114X | ||
024 | 7 |
_a10.1016/j.clinthera.2016.07.010 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLugogo, Njira | |
245 | 0 | 0 |
_aLong-term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-center, Open-label, Phase IIIb Study. _h[electronic resource] |
260 |
_bClinical therapeutics _cSep 2016 |
||
300 |
_a2058-2070.e1 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
650 | 0 | 4 | _aAdministration, Intravenous |
650 | 0 | 4 |
_aAdrenal Cortex Hormones _xtherapeutic use |
650 | 0 | 4 |
_aAnti-Asthmatic Agents _xadministration & dosage |
650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xadministration & dosage |
650 | 0 | 4 |
_aAsthma _xdrug therapy |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 |
_aEosinophilia _xdrug therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlucocorticoids _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInjections, Subcutaneous |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aDomingo, Christian | |
700 | 1 | _aChanez, Pascal | |
700 | 1 | _aLeigh, Richard | |
700 | 1 | _aGilson, Martyn J | |
700 | 1 | _aPrice, Robert G | |
700 | 1 | _aYancey, Steven W | |
700 | 1 | _aOrtega, Hector G | |
773 | 0 |
_tClinical therapeutics _gvol. 38 _gno. 9 _gp. 2058-2070.e1 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.clinthera.2016.07.010 _zAvailable from publisher's website |
999 |
_c26353781 _d26353781 |